Wednesday, May 13, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result

Rocket Lab Transforms from Launch Specialist to Full-Scale Space Supplier as Orders Hit $2.2 Billion

Kennethcix by Kennethcix
May 13, 2026
in Uncategorized
0
Rocket Lab USA Stock
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

The narrative around Rocket Lab USA is shifting fast. What was once viewed primarily as a small-satellite launch provider is now being re-evaluated as an integrated aerospace supplier, after the company’s space systems division pulled ahead of its traditional rocket-launch business in quarterly revenue for the first time.

First-quarter 2026 revenue hit $200.3 million, a 63.5% jump from a year earlier and comfortably above the consensus estimate of roughly $190.9 million. The outperformance was driven by the Space Systems segment, which sells satellite components, subsystems and full mission solutions. The company also booked 31 new launch contracts during the quarter, adding to a pipeline that now looks remarkably deep.

The order backlog swelled to a record $2.2 billion, a 20.2% increase from the previous quarter. That figure includes the largest launch agreement in Rocket Lab’s history, covering multiple missions with both the workhorse Electron and the upcoming Neutron rocket through 2029. CEO Peter Beck pointed to a Pentagon block order worth $190 million for military HASTE missions and a $30 million contract with Anduril Industries for hypersonic test flights as key contributors.

Management’s guidance for the second quarter signals continued momentum. Revenue is expected to land between $225 million and $240 million, with the midpoint of $232.5 million running about 12% ahead of prior analyst forecasts. The company also aims to deliver adjusted operating profit of roughly $23 million, narrowing its GAAP net loss to $45.02 million from the year-ago level.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

A strategic acquisition bolsters the supply-chain story. Rocket Lab agreed to buy Motiv Space Systems, a California-based robotics specialist, for $60 million. The deal, expected to close in the second quarter, will bring in roughly 50 engineers and technicians whose components — including solar array drive assemblies and motor controllers — already fly on high-profile missions such as the Mars Perseverance rover and CADRE lunar rovers. The unit will operate as Rocket Lab Robotics, further deepening the company’s vertical integration.

The stock has been pricing in that optimism aggressively. After a 44% surge in a matter of days following the earnings release, shares hit an all-time high of $123.94 before settling at $117.56 at Tuesday’s close. That leaves Rocket Lab up 38.88% in a single week and a staggering 438.52% over the past 12 months. Analysts at Deutsche Bank, Bank of America and Needham all lifted their price targets to $120, while Morgan Stanley upgraded the stock to “Overweight.”

CFO Adam Spice noted an additional macro tailwind: the anticipated initial public offering of SpaceX, expected in June, could funnel more capital toward established space players and squeeze out weaker rivals. SpaceX’s rumored valuation of around $1.5 trillion sets a powerful benchmark for the entire sector.

Yet the soaring share price leaves little room for error. Rocket Lab is still burning cash on the capital-intensive development of Neutron, its medium-lift rocket designed to compete head-to-head with SpaceX’s Falcon 9. The first flight is scheduled for the fourth quarter of 2026, and any delay could quickly puncture the rally. Analysts caution that with so much expectation already baked into the valuation, the company must now convert its record backlog into predictable revenue growth without eroding margins. Execution on Neutron will be the defining test of whether this transformation is sustainable.

Ad

Rocket Lab USA Stock: Buy or Sell?! New Rocket Lab USA Analysis from May 13 delivers the answer:

The latest Rocket Lab USA figures speak for themselves: Urgent action needed for Rocket Lab USA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from May 13.

Rocket Lab USA: Buy or sell? Read more here...

Tags: Rocket Lab USA
Kennethcix

Kennethcix

Related Posts

SoftBank Stock

SoftBank Reports Historic ¥5 Trillion Profit, but a Funding Pullback Reveals Creeping Caution

May 13, 2026
Onco-Innovations Stock

Pharma Giants AstraZeneca and GSK Tap Onco-Innovations’ Causal AI to Sharpen Cancer Trial Predictions

May 13, 2026
WisdomTree Silver 3x Daily Leveraged Stock
Commodities

With a 1-for-10 Split Behind It, WisdomTree’s Triple-Leveraged Silver Fund Faces Its Toughest Test Yet

May 13, 2026
Next Post
Onco-Innovations Stock

Pharma Giants AstraZeneca and GSK Tap Onco-Innovations' Causal AI to Sharpen Cancer Trial Predictions

SoftBank Stock

SoftBank Reports Historic ¥5 Trillion Profit, but a Funding Pullback Reveals Creeping Caution

Recommended

USMC stock news

SG Americas Securities LLC Decreases Stake in Teekay Co., Signaling Potential Shift in Investment Strategy

3 years ago
VanEck Gold Miners ETF Stock

Gold Mining Stocks Surge as Precious Metal Hits Record Highs

6 months ago
Iris Energy Stock

Iris Energy’s Strategic Pivot: From Bitcoin Mining to AI Infrastructure Powerhouse

6 months ago
Unitedhealth Stock

UnitedHealth’s Strategic Moves Signal Potential Turnaround

8 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

With a 1-for-10 Split Behind It, WisdomTree’s Triple-Leveraged Silver Fund Faces Its Toughest Test Yet

Intel’s Nvidia Deal and $5 Billion Vote of Confidence Overshadowed by Market Headwinds

Quantum eMotion’s Taiwan Test Marks the First Step in a Quantum-Safe Energy Pivot

Aixtron’s Optoelectronics Pivot Fuels a Record Order Book, but the Profit Engine Still Needs Time

Palantir Strikes SAP Deal, But NHS Data Storm Clouds Loom Over Growth Story

Sivers Draws Institutional Firepower as Nasdaq Listing and New mmWave Deal Overlap

Trending

SoftBank Stock

SoftBank Reports Historic ¥5 Trillion Profit, but a Funding Pullback Reveals Creeping Caution

by SiterGedge
May 13, 2026
0

When Masayoshi Son’s SoftBank Group unveils a net profit that dwarfs anything a Japanese company has ever...

Onco-Innovations Stock

Pharma Giants AstraZeneca and GSK Tap Onco-Innovations’ Causal AI to Sharpen Cancer Trial Predictions

May 13, 2026
Rocket Lab USA Stock

Rocket Lab Transforms from Launch Specialist to Full-Scale Space Supplier as Orders Hit $2.2 Billion

May 13, 2026
WisdomTree Silver 3x Daily Leveraged Stock

With a 1-for-10 Split Behind It, WisdomTree’s Triple-Leveraged Silver Fund Faces Its Toughest Test Yet

May 13, 2026
Intel Stock

Intel’s Nvidia Deal and $5 Billion Vote of Confidence Overshadowed by Market Headwinds

May 13, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • SoftBank Reports Historic ¥5 Trillion Profit, but a Funding Pullback Reveals Creeping Caution
  • Pharma Giants AstraZeneca and GSK Tap Onco-Innovations’ Causal AI to Sharpen Cancer Trial Predictions
  • Rocket Lab Transforms from Launch Specialist to Full-Scale Space Supplier as Orders Hit $2.2 Billion

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com